SCHEMBL162370

SCHEMBL162370

C[C@@](N)(CCCN)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 1/20 0.59
ARG2 P78540 1/20 0.59
GGT1 P19440 1/20 0.54
ODC1 P11926 2/20 0.52
BLM P54132 5/20 0.48
LMNA P02545 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
PMP22 Q01453 2/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 3/20 0.39
THRB P10828 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 2/20 0.39
GABRR3 A8MPY1 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
HDAC3 O15379 1/20 0.39
GABBR2 O75899 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL162369 1.00 ARG1 (0.59) ARG1ARG2GGT1ODC1BLM
SCHEMBL574141 1.00 ARG1 (0.59) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL11675620 0.98 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Water SCHEMBL7726696 0.98 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Water SCHEMBL7726693 0.98 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL8707966 0.98 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL3219766 0.98 ARG1 (0.57) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL6958032 0.96 ARG1 (0.55) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL6958034 0.96 ARG1 (0.55) ARG1ARG2GGT1ODC1BLM
Hydrochloric Acid SCHEMBL6958028 0.96 ARG1 (0.55) ARG1ARG2GGT1ODC1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2442 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169403-B9 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-07-03 EP claimed
EP-3169403-B1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-02-14 EP claimed
WO-2023085973-A1 PHARMACUETICAL COMPOSITIONS FOR TREATING INFLAMMATORY INFECTIOUS DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ВАЛЕНТА-ИНТЕЛЛЕКТ" 2023-05-19 WO claimed
US-20220226496-A1 LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE LEGOCHEM BIOSCIENCES, INC. (KR) 2022-07-21 US claimed
EP-3964236-A1 LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE LegoChem Biosciences, Inc. (KR) 2022-03-09 EP claimed
CN-113727734-A Ligand-drug conjugates comprising a linker having a tris structure 乐高化学生物科学股份有限公司 2021-11-30 CN claimed
US-11167040-B2 Conjugates comprising peptide groups and methods related thereto LEGOCHEM BIOSCIENCES, INC. (KR) 2021-11-09 US claimed
CN-107206254-B Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel disease 领导医疗有限公司 2021-08-24 CN claimed
EP-3380125-A1 CONJUGATES COMPRISING PEPTIDE GROUPS AND METHODS RELATED THERETO LegoChem Biosciences, Inc. (KR) 2018-10-03 EP claimed
WO-2017089894-A1 CONJUGATES COMPRISING PEPTIDE GROUPS AND METHODS RELATED THERETO LEGOCHEM BIOSCIENCES, INC. (KR) 2017-06-01 WO claimed
US-20070032417-A1 Peptides and therapeutic uses thereof WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-02-08 US claimed
US-7070969-B1 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis THE UNIVERSITY OF QUEENSLAND (AU) 2006-07-04 US claimed
WO-2006000034-A1 CONJUGATES AND THERAPEUTIC USES THEREOF THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-05 WO claimed
WO-2004058804-A1 PEPTIDES AND THERAPEUTIC USES THEREOF WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2004-07-15 WO claimed
US-5872104-A BACTERICIDES AND RESISTANT BACTERIA WITH METHYLATION INHIBITORS ORIDIGM CORPORATION (US) 1999-02-16 US claimed
EP-0703731-B1 FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT, AND THERAPEUTICAL USES THEREOF UNIV RENNES (FR) 1998-04-08 EP claimed
EP-0703732-B1 FOOD AND/OR PHARMACEUTICAL COMPOSITION HAVING A LOW POLYAMINE CONTENT UNIV RENNES (FR) 1997-09-17 EP claimed
CN-1126999-A Peptide compounds having oxytocin antagonist activity FERRING BV (NL) 1996-07-17 CN claimed
WO-1996020010-A1 COMBINATION FOR REDUCING ANTIMICROBIAL RESISTANCE USING A METHYLATION INHIBITOR IN COMBINATION WITH AN ANTIBIOTIC ORIDIGM CORPORATION (US) 1996-07-04 WO claimed
US-4751348-A USING ULTRAVIOLET LIGHT MUTAGEN, POLYAMINE SYNTEHSIS INHIBITORS, AND GROWTH IN THE DARK COLD SPRING HARBOR LABORATORY (US) 1988-06-14 US claimed